| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.24B | 26.04B | 26.83B | 24.07B | 15.22B | 13.27B |
| Gross Profit | 16.24B | 16.76B | 17.04B | 15.96B | 12.58B | 11.36B |
| EBITDA | 4.77B | 8.82B | 9.10B | 7.70B | 5.05B | 6.01B |
| Net Income | 6.06B | 5.89B | 5.79B | 4.82B | 3.13B | 5.23B |
Balance Sheet | ||||||
| Total Assets | 659.82B | 664.04B | 631.00B | 607.17B | 598.85B | 680.04B |
| Cash, Cash Equivalents and Short-Term Investments | 49.19B | 45.83B | 50.63B | 4.16B | 20.52B | 104.28B |
| Total Debt | 51.17B | 85.50B | 77.54B | 84.50B | 50.09B | 50.74B |
| Total Liabilities | 622.39B | 625.51B | 594.14B | 570.83B | 565.14B | 644.61B |
| Stockholders Equity | 37.42B | 38.51B | 36.83B | 36.31B | 33.67B | 35.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 41.97B | 16.53B | 14.94B | -80.79B | 37.95B |
| Operating Cash Flow | 0.00 | 42.36B | 16.85B | 15.74B | -79.88B | 38.63B |
| Investing Cash Flow | 0.00 | -37.98B | -152.00M | 203.00M | 164.00M | 13.89B |
| Financing Cash Flow | 0.00 | -8.35B | -4.75B | 1.39B | -3.98B | 88.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | €70.06B | 12.48 | 15.73% | 4.05% | -7.50% | 12.76% | |
68 Neutral | €107.26B | 11.93 | 18.66% | 3.39% | 5.66% | 8.16% | |
66 Neutral | €15.35B | 10.53 | 7.75% | 7.43% | -6.77% | -39.63% | |
64 Neutral | €12.09B | 11.67 | 16.71% | 3.64% | -7.12% | 15.96% | |
62 Neutral | $6.39B | 13.74 | 8.76% | 5.80% | -9.39% | 45.60% | |
60 Neutral | £141.00B | 10.62 | 12.91% | 1.82% | -16.49% | 14.32% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |